Edition:
United Kingdom

Kindred Biosciences Inc (KIN.OQ)

KIN.OQ on NASDAQ Stock Exchange Capital Market

8.00USD
2:35pm GMT
Change (% chg)

$-0.05 (-0.62%)
Prev Close
$8.05
Open
$8.10
Day's High
$8.10
Day's Low
$8.00
Volume
1,927
Avg. Vol
18,594
52-wk High
$9.60
52-wk Low
$4.20

Chart for

About

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company. The Company is focused on developing therapies for pets. The Company's product pipeline consists of small molecules and biologics for a range of indications in dogs, cats and horses. The Company is developing product candidates for over 20 indications... (more)

Overall

Beta: 0.21
Market Cap(Mil.): $225.49
Shares Outstanding(Mil.): 27.84
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-KindredBio Announces Positive Results From Pivotal Study Of Zimeta Oral

* KINDREDBIO ANNOUNCES POSITIVE RESULTS FROM PIVOTAL STUDY OF ZIMETA ORAL FOR FEVER IN HORSES

04 Dec 2017

BRIEF-Kindred Biosciences posts Q3 loss of $0.29 per share

* Kindred biosciences announces third quarter 2017 financial results

07 Nov 2017

BRIEF-Kindred Biosciences Q2 loss per share $0.29

* Kindred Biosciences announces second quarter 2017 financial results

07 Aug 2017

BRIEF-Kindredbio announces proposed public offering of common stock

* Kindredbio announces proposed public offering of common stock

11 Jul 2017

Earnings vs. Estimates